Tech Company Financing Transactions
Synlogic Funding Round
On 6/30/2015, Synlogic raised $29.4 million in Series A investment from private investors.
Transaction Overview
Company Name
Announced On
6/30/2015
Transaction Type
Venture Equity
Amount
$29,400,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
301 Binney St. 402
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Synlogic leverages the most advanced technology platform available for the creation of synthetically engineered, therapeutic microbes with the potential to make significant advancements in the treatment of disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Aoife Brennan
Chief Financial Officer
Todd Shegog
Chief Scientific Officer
Scott Plevy
VP - General Counsel
Maiken Keson-Brookes
VP - Human Resources
Adam Thomas
VP - Operations
Antoine Awad
VP - Product Management
Caroline Kurtz
Browse more venture capital transactions:
Prev: 6/30/2015: Cadherx Therapeutics venture capital transaction
Next: 6/30/2015: Wulou Labs venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs